Related Experiment Video
Updated: Mar 30, 2026

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
Paced QT interval as a risk factor for new-onset left ventricular systolic dysfunction and cardiac death after
Eun Jeong Cho1, Seung-Jung Park2, Kyoung Min Park2
1Cardiology Clinic, National Cancer Center, Gyeonggi-do, Republic of Korea.
Insights
Prolonged paced-corrected QT (p-QTc) intervals after pacemaker implantation are linked to new left ventricular systolic dysfunction (new-LVSD) and cardiac death. This risk is especially high in patients with both wider p-QTc intervals and new-LVSD.
Area of Science:
- Cardiology
- Electrophysiology
- Cardiac Pacing
Background:
- Prolonged corrected QT (QTc) interval is a known risk factor for fatal arrhythmias and cardiac death.
- The association between paced-QTc (p-QTc) interval and new-onset left ventricular systolic dysfunction (new-LVSD) or cardiac death post-pacemaker implantation is not well-established.
Purpose of the Study:
- To investigate the relationship between the p-QTc interval and the incidence of new-LVSD and cardiac death in patients receiving permanent pacemaker (PPM) implantation.
- To determine if p-QTc interval prolongation is an independent predictor of adverse cardiac events after PPM.
Main Methods:
- A cohort of 491 patients with preserved left ventricular ejection fraction undergoing PPM implantation were studied.
- The p-QTc interval was measured within two weeks post-implantation, and patients were followed for new-LVSD and cardiac death.
- Statistical analyses, including Cox regression, were used to assess the association between p-QTc interval and outcomes.
Main Results:
- During a median follow-up of 78 months, 10.8% developed new-LVSD and 5.3% experienced cardiac death.
- Patients with new-LVSD showed more frequent atrioventricular block, higher ventricular pacing percentage, longer p-QRS duration, and prolonged p-QTc intervals.
- A graded increase in new-LVSD and cardiac death rates was observed across tertiles of p-QTc interval, with independent association found in Cox regression.
Conclusions:
- Prolonged p-QTc interval is significantly associated with new-LVSD and cardiac death in patients with preserved LV function after PPM implantation.
- The risk of cardiac death is particularly elevated in patients with both new-LVSD and a wider p-QTc interval.
Background:
Prolongation of corrected QT (QTc) interval reflects an increased risk of fatal arrhythmia and cardiac death in various populations. However, it is not clear whether the paced-QTc (p-QTc) interval is associated with new-onset left ventricular systolic dysfunction (new-LVSD) or cardiac death.
Methods:
In 491 consecutive patients (64 ± 14 years) with preserved LV ejection fraction (64 ± 7%), the p-QTc interval was measured within 2 weeks after PPM implantation. We assessed the rates of new-LVSD and cardiac death based on the degree of p-QTc interval.
Results:
During the follow-up period (78 ± 51 months), new-LVSD and cardiac death were identified in 53 (10.8%) and 26 (5.3%) patients, respectively. Patients with new-LVSD had more frequent atrioventricular block (P=0.041), a higher percentage of ventricular pacing (P=0.005), a longer p-QRS duration (P<0.001), and more prolonged p-QTc interval (P<0.001) compared to those without new-LVSD. There was a graded increase in the rates of new-LVSD (P<0.001) and cardiac death (P=0.001) from the patients in the lowest to those in the highest tertile of the p-QTc interval. Additionally, the incidence of cardiac death was significantly elevated especially in the patients with new-LVSD and wider p-QTc interval. In Cox regression analyses, the p-QTc interval was independently associated with new-LVSD and cardiac death even after adjusted with various relevant confounding factors.
Conclusions:
Prolonged p-QTc interval was closely associated with new-LVSD and cardiac death after PPM implantation in patients with preserved LV systolic function. The rate of cardiac death significantly increased especially in patients who showed more p-QTc widening along with new-LVSD.
More Related Videos
Related Concept Videos
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Mechanism of Cardiac Arrhythmias

